Finkbohner R, Johnston D, Crawford E S, Coselli J, Milewicz D M
Department of Internal Medicine, University of Texas Medical School at Houston 77036.
Circulation. 1995 Feb 1;91(3):728-33. doi: 10.1161/01.cir.91.3.728.
Development of surgical therapy for aortic aneurysms and dissections has led to treatment of the life-threatening cardiovascular complications associated with Marfan syndrome. The present study determines the effect of surgical therapy on the life expectancy of patients with Marfan syndrome and the clinical course of these patients after aortic aneurysm repair.
Medical records were reviewed on 192 patients with Marfan syndrome who underwent aortic aneurysm repair during the past 26 years; 103 patients were interviewed, and complete preoperative and postoperative medical information was obtained. Survival curves were generated, and data were analyzed. The median cumulative probability of survival was 61 years, significantly increased compared with the median survival of 47 years for patients with Marfan syndrome determined 30 years ago (P < .0006). The majority of patients (53%) had second surgeries to repair subsequent aneurysms or dissections at other sites, the vast majority of which involved the aorta. The most common pattern of aneurysm repair was proximal ascending aortic aneurysm repair, followed by descending thoracic aneurysm surgery. The following variables predicted patients requiring second vascular surgeries: presence of acute or chronic dissection at the time of the first surgery, hypertension after the first surgery, and a history of smoking.
The life expectancy of patients with Marfan syndrome undergoing surgical repair of aortic aneurysms has improved and is consistent with increased survival. After initial repair of an ascending aortic aneurysm, a significant number of patients have subsequent surgeries at other sites throughout the aorta, indicating Marfan syndrome is a disease involving the entire aorta. Patients who had a dissection at the time of the first aortic surgery were more likely to require subsequent aortic surgery than were patients who underwent prophylactic composite graft repair of an aortic aneurysm.
主动脉瘤和主动脉夹层手术治疗的发展已使得与马凡综合征相关的危及生命的心血管并发症得到治疗。本研究确定手术治疗对马凡综合征患者预期寿命的影响以及这些患者在主动脉瘤修复后的临床病程。
回顾了过去26年中192例行主动脉瘤修复术的马凡综合征患者的病历;对103例患者进行了访谈,并获得了完整的术前和术后医疗信息。生成生存曲线并进行数据分析。中位累积生存概率为61岁,与30年前确定的马凡综合征患者47岁的中位生存期相比显著增加(P <.0006)。大多数患者(53%)进行了二次手术以修复其他部位随后出现的动脉瘤或夹层,其中绝大多数累及主动脉。最常见的动脉瘤修复方式是近端升主动脉瘤修复,其次是降胸主动脉瘤手术。以下变量可预测患者需要进行二次血管手术:首次手术时存在急性或慢性夹层、首次手术后高血压以及吸烟史。
接受主动脉瘤手术修复的马凡综合征患者的预期寿命有所改善,且与生存率提高一致。在首次修复升主动脉瘤后,相当数量的患者在主动脉的其他部位进行了后续手术,这表明马凡综合征是一种累及整个主动脉的疾病。与接受主动脉瘤预防性复合移植物修复的患者相比,首次主动脉手术时出现夹层的患者更有可能需要后续的主动脉手术。